I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kyi, Chrisann
53
results:
Search for persons
X
Format
Online (53)
Mediatypes
Articles (Online) (21)
Bookchapter (Online) (1)
OpenAccess-fulltext (31)
Sorted by: Relevance
Sorted by: Year
?
1
A shared neoantigen vaccine combined with immune checkpoint..:
Rappaport, Amy R.
;
Kyi, Chrisann
;
Lane, Monica
...
Nature Medicine. 30 (2024) 4 - p. 1013-1022 , 2024
Link:
https://doi.org/10.1038/..
?
2
Nivolumab for mismatch-repair-deficient or hypermutated gyn..:
Friedman, Claire F.
;
Manning-Geist, Beryl L.
;
Zhou, Qin
...
Nature Medicine. 30 (2024) 5 - p. 1330-1338 , 2024
Link:
https://doi.org/10.1038/..
?
3
Basket study of oral progesterone antagonist onapristone ex..:
Andres, Sarah
;
Finch, Lindsey
;
Iasonos, Alexia
...
Gynecologic Oncology. 189 (2024) - p. 30-36 , 2024
Link:
https://doi.org/10.1016/..
?
4
A phase 2 trial of zanidatamab in HER2-overexpressed advanc..:
Lumish, Melissa
;
Chui, M. Herman
;
Zhou, Qin
...
Gynecologic Oncology. 182 (2024) - p. 75-81 , 2024
Link:
https://doi.org/10.1016/..
?
5
A phase 2, multicenter, open-label study of anti-LAG-3 iera..:
Lin, Chia-Chi
;
Garralda, Elena
;
Schöffski, Patrick
...
OncoImmunology. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1080/..
?
6
Mitogen-Activated Protein Kinase Driven Rare Gynecologic Ca..:
Grisham, Rachel N.
;
Praiss, Aaron
;
Kyi, Chrisann
.
Advances in Oncology. 3 (2023) 1 - p. 47-53 , 2023
Link:
https://doi.org/10.1016/..
?
7
Assessing the Genomic Landscape of Cervical Cancers: Clinic..:
Friedman, Claire F.
;
Ravichandran, Vignesh
;
Miller, Kathryn
...
Clinical Cancer Research. 29 (2023) 22 - p. 4660-4668 , 2023
Link:
https://doi.org/10.1158/..
?
8
Dual targeting ovarian cancer by Muc16 CAR T cells secretin..:
Mun, Sung Soo
;
Meyerberg, Jeremy
;
Peraro, Leila
...
Cancer Immunology, Immunotherapy. 72 (2023) 11 - p. 3773-3786 , 2023
Link:
https://doi.org/10.1007/..
?
9
Is there a Role for Immunotherapy in Treatment of Cervical ..:
, In:
50 Big Debates in Gynecologic Oncology
,
Kyi, Chrisann
;
Zamarin, Dmitriy
- p. 285-287 , 2023
Link:
https://doi.org/10.1017/..
?
10
Durvalumab with or without tremelimumab in patients with pe..:
Rubinstein, Maria M.
;
Doria, Eric Rios
;
Konner, Jason
...
Gynecologic Oncology. 169 (2023) - p. 64-69 , 2023
Link:
https://doi.org/10.1016/..
?
11
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:
Schöffski, Patrick
;
Tan, Daniel S W
;
Martín, Miguel
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 2 - p. e003776 , 2022
Link:
https://doi.org/10.1136/..
?
12
Gastric-type adenocarcinoma of the cervix: Clinical outcome..:
Ehmann, Sarah
;
Sassine, Dib
;
Straubhar, Alli M.
...
Gynecologic Oncology. 167 (2022) 3 - p. 458-466 , 2022
Link:
https://doi.org/10.1016/..
?
13
Pattern of disease and response to pembrolizumab in recurre..:
Miller, Kathryn M.
;
Filippova, Olga T.
;
Hayes, Sara A.
...
Gynecologic Oncology Reports. 37 (2021) - p. 100831 , 2021
Link:
https://doi.org/10.1016/..
?
14
Neoadjuvant nivolumab for patients with resectable HPV-posi..:
Ferris, Robert L
;
Spanos, William C
;
Leidner, Rom
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002568 , 2021
Link:
https://doi.org/10.1136/..
?
15
Phase I dose escalation safety and feasibility study of aut..:
Kyi, Chrisann
;
Doubrovina, Ekaterina
;
Zhou, Qin
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 8 - p. e002752 , 2021
Link:
https://doi.org/10.1136/..
1-15